Holen Sie sich die Stockscreener-App
26.90
12.38%
-3.80
Handel nachbörslich:
26.35
-0.55
-2.04%
Schlusskurs vom Vortag:
$30.70
Offen:
$29.55
24-Stunden-Volumen:
2.72M
Relative Volume:
2.73
Marktkapitalisierung:
$2.55B
Einnahmen:
$47.30M
Nettoeinkommen (Verlust:
$-225.97M
KGV:
-11.45
EPS:
-2.35
Netto-Cashflow:
$-188.86M
1W Leistung:
-18.09%
1M Leistung:
-27.47%
6M Leistung:
+262.53%
1J Leistung:
+86.81%
1-Tages-Spanne:
$26.65
$30.00
1-Wochen-Bereich:
$26.65
$32.91
52-Wochen-Spanne:
$6.76
$46.98
Scholar Rock Holding Corp Stock (SRRK) Company Profile
Firmenname
Scholar Rock Holding Corp
Sektor
Branche
Telefon
857-259-3860
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie SRRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SRRK
Scholar Rock Holding Corp
|
26.90 | 2.55B | 47.30M | -225.97M | -188.86M | -2.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Scholar Rock Holding Corp Stock (SRRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-26 | Bestätigt | H.C. Wainwright | Buy |
| 2024-10-07 | Bestätigt | H.C. Wainwright | Buy |
| 2024-03-28 | Eingeleitet | Raymond James | Strong Buy |
| 2023-10-25 | Hochstufung | Jefferies | Hold → Buy |
| 2023-04-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-07-12 | Eingeleitet | Truist | Buy |
| 2022-03-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-22 | Herabstufung | Jefferies | Buy → Hold |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-01-11 | Eingeleitet | Credit Suisse | Outperform |
| 2021-01-06 | Eingeleitet | JP Morgan | Overweight |
| 2020-03-12 | Eingeleitet | Robert W. Baird | Outperform |
Alle ansehen
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Scholar Rock (NASDAQ:SRRK) Trading Up 6.6%Here's What Happened - MarketBeat
Norges Bank Takes $86.04 Million Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
DnB Asset Management AS Sells 8,527 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
194,668 Shares in Scholar Rock Holding Co. (NASDAQ:SRRK) Purchased by Pictet Asset Management Holding SA - MarketBeat
KLP Kapitalforvaltning AS Invests $536,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock (NASDAQ:SRRK) Shares Down 5.5%Time to Sell? - MarketBeat
Scholar Rock Holding Co. (NASDAQ:SRRK) Position Boosted by Sei Investments Co. - Defense World
Corebridge Financial Inc. Buys 1,915 Shares of Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
American Century Companies Inc. Makes New $28.39 Million Investment in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Loomis Sayles & Co. L P Invests $33.57 Million in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
BIT Capital GmbH Cuts Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Teacher Retirement System of Texas Has $752,000 Stake in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Corient Private Wealth LLC Takes $394,000 Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Raymond James Financial Inc. Takes Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Wedbush Reiterates Outperform Rating for Scholar Rock (NASDAQ:SRRK) - MarketBeat
Insider Selling: Scholar Rock Holding Co. (NASDAQ:SRRK) Insider Sells 6,500 Shares of Stock - MarketBeat
Swiss National Bank Grows Stock Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Victory Capital Management Inc. Invests $374,000 in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock stock holds $45 target, buoyed by FDA priority review - Investing.com India
Scholar Rock (NASDAQ:SRRK) Given “Outperform” Rating at Wedbush - Defense World
Scholar Rock interim PFO sells $449k in stock By Investing.com - Investing.com South Africa
Scholar Rock chief commercial officer sells $215k in stock By Investing.com - Investing.com South Africa
Scholar Rock chief commercial officer sells $215k in stock - Investing.com
Scholar Rock interim PFO sells $449k in stock - Investing.com India
FDA accepts Scholar Rock BLA for apitegromab under priority review to treat SMA - TipRanks
Is It Time For Me To Buy Scholar Rock Holding Corp (NASDAQ: SRRK) Stock Now? - Stocks Register
CrowdStrike, Scholar Rock, Cloudflare - TradingView
Scholar Rock Gets US FDA Priority Review for Potential Spinal Muscular Atrophy Treatment - Marketscreener.com
FDA Grants Priority Review for Biologics License Application (BLA) and EMA Accepts Marketing Authorisation Application (MAA) for Apitegromab as a Treatment for Spinal Muscular Atrophy - MarketScreener
Swiss National Bank Boosts Stock Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Scholar Rock Holding Co. (NASDAQ:SRRK) Director Sells $34,626.52 in Stock - MarketBeat
AlphaQuest LLC Reduces Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Victory Capital Management Inc. Takes Position in Scholar Rock Holding Co. (NASDAQ:SRRK) - Defense World
Skandinaviska Enskilda Banken AB publ Purchases New Shares in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Proficio Capital Partners LLC Invests $2.37 Million in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Holdings in Scholar Rock Holding Co. (NASDAQ:SRRK) - MarketBeat
Scholar Rock (NASDAQ:SRRK) Given "Outperform" Rating at Wedbush - MarketBeat
Scholar Rock appoints Erin Moore as interim Principal Financial Officer -March 21, 2025 at 04:36 pm EDT - MarketScreener
Finanzdaten der Scholar Rock Holding Corp-Aktie (SRRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):